工程气凝颗粒作为下一代药物输送系统:对最近的进展进行全面审查
Susana M Gomes1, Carlos Illanes-Bordomás1, Carlos A García-González1
1AerogelsLab, I+D Farma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela E-15782 Santiago de Compostela, Spain.
International journal of pharmaceutics
|March 1, 2026
概括
气凝颗粒提供先进的药物输送解决方案,增强生物相容性,稳定性和针对性释放,用于口腔,皮肤和肺部应用. 这些工程材料显示出下一代治疗方法的前景.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 气凝是低密度,高度的材料,具有高的特定表面积.
- 气凝颗粒被设计用于各种应用,包括药物输送系统.
- 最近的进展侧重于优化气凝颗粒,以提高生物相容性,稳定性和向药物输送.
研究的目的:
- 审查和合成用于药物输送的气凝颗粒设计的最先进技术.
- 对空气凝颗粒的工程技术和表面修饰技术进行批判性讨论.
- 突出气凝颗粒技术的生物医学应用和未来趋势.
主要方法:
- 综述了气凝颗粒工程最近的进展.
- 批判性讨论滴滴生产和颗粒制造的研磨技术.
- 检查表面修饰和涂层技术以提高性能.
主要成果:
- 气凝颗粒显示改善药物加载和持续释放,用于口服.
- 它们显示出增强皮肤透和持续释放在皮肤输送中的潜力.
- 低密度和空气动力学特性有利于肺部深层沉积,用于肺部管理.
结论:
- 气凝颗粒为下一代基于气凝的治疗系统提供了独特的功能.
- 工程策略可以提高生物相容性,稳定性和向药物输送.
- 需要进一步的研究来应对当前的挑战,并探索气凝颗粒技术的未来趋势.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Drug Delivery: Overview
1.0K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.0K
Drug Delivery Systems: Different Types
107
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
107
Modified-Release Drug Delivery Systems: Overview
69
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
69
Oral Drug Delivery Systems: Introduction
85
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
85
Modified-Release Drug Delivery Systems: Classification
105
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
105


